Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bolt Biotherapeutics (BOLT) Prepaid Assets (2020 - 2025)

Bolt Biotherapeutics (BOLT) has disclosed Prepaid Assets for 6 consecutive years, with $2.6 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets rose 380.26% to $2.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.6 million through Dec 2025, up 380.26% year-over-year, with the annual reading at $2.6 million for FY2025, 380.26% up from the prior year.
  • Prepaid Assets hit $2.6 million in Q4 2025 for Bolt Biotherapeutics, down from $2.9 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $9.6 million in Q3 2021 to a low of $532000.0 in Q4 2024.
  • Historically, Prepaid Assets has averaged $3.9 million across 5 years, with a median of $3.6 million in 2022.
  • Biggest five-year swings in Prepaid Assets: tumbled 84.88% in 2024 and later skyrocketed 380.26% in 2025.
  • Year by year, Prepaid Assets stood at $2.9 million in 2021, then soared by 31.18% to $3.9 million in 2022, then fell by 8.79% to $3.5 million in 2023, then crashed by 84.88% to $532000.0 in 2024, then soared by 380.26% to $2.6 million in 2025.
  • Business Quant data shows Prepaid Assets for BOLT at $2.6 million in Q4 2025, $2.9 million in Q3 2025, and $2.8 million in Q2 2025.